Unlocking potential in good health and well-being

longevity VENTURES II

Advancements in technology, data, and analytics are enabling payers and providers the capabilities to tailor the consumer experience at scale for truly personalized health. 
​
We invest in frontier human optimization technology that promote longer, healthier and happier lives.
Stage:
Pre-seed, Seed, Series+
Focus:
Artificial Intelligence
Blockchain Technology
Digital Therapeutics
Neurotechnology
​New Pharmacology
Investment:
Up to $10m USD
Geography:
Global
Limited Partners
  • Investment exposure to frontier human optimization
  • Robust pipeline of early leaders in micro trends​
  • Non-dilutive CAD government funds​
  • Investment committee with deep experience in healthcare and technology
  • Strong advisory team and network of later stage funds to help with due diligence
  • Diversified portfolio with low correlation to market indices
Portfolio Companies
  • Early investors enabling scientific research and experimental development
  • Flexible with no revenue or earnings minimums
  • Long term time horizon focused on innovation
  • Government grant funding available
  • Corporate development and board advisory 
  • Large network of later stage funds for introductions​
  • Commitment to participate in subsequent rounds of financing
No Offer or Solicitation of Securities: This page is meant for the direct recipient of the Investment Manager for general discussion purposes only and does not constitute an offer to sell or buy any security in any jurisdiction. Reproduction or further distribution of any part of this page is strictly prohibited.